- Home
- PHGE vs CDIO Comparison
PHGE vs CDIO Comparison
Compare PHGE & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- CDIO
- Stock Information
- Founded
- PHGE 2015
- CDIO 2017
- Country
- PHGE Israel
- CDIO United States
- Employees
- PHGE N/A
- CDIO N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PHGE Health Care
- CDIO Health Care
- Exchange
- PHGE Nasdaq
- CDIO Nasdaq
- Market Cap
- PHGE 13.3M
- CDIO 12.3M
- IPO Year
- PHGE N/A
- CDIO N/A
- Fundamental
- Price
- PHGE $0.74
- CDIO $0.63
- Analyst Decision
- PHGE Strong Buy
- CDIO Buy
- Analyst Count
- PHGE 2
- CDIO 1
- Target Price
- PHGE $13.50
- CDIO $2.00
- AVG Volume (30 Days)
- PHGE 110.1K
- CDIO 2.1M
- Earning Date
- PHGE 11-14-2024
- CDIO 11-13-2024
- Dividend Yield
- PHGE N/A
- CDIO N/A
- EPS Growth
- PHGE N/A
- CDIO N/A
- EPS
- PHGE N/A
- CDIO N/A
- Revenue
- PHGE N/A
- CDIO $35,688.00
- Revenue This Year
- PHGE N/A
- CDIO $2,081.66
- Revenue Next Year
- PHGE N/A
- CDIO $43.84
- P/E Ratio
- PHGE N/A
- CDIO N/A
- Revenue Growth
- PHGE N/A
- CDIO 180.90
- 52 Week Low
- PHGE $0.48
- CDIO $0.19
- 52 Week High
- PHGE $8.55
- CDIO $2.40
- Technical
- Relative Strength Index (RSI)
- PHGE 54.26
- CDIO 45.49
- Support Level
- PHGE $0.70
- CDIO $0.51
- Resistance Level
- PHGE $0.80
- CDIO $0.62
- Average True Range (ATR)
- PHGE 0.06
- CDIO 0.12
- MACD
- PHGE 0.00
- CDIO -0.04
- Stochastic Oscillator
- PHGE 41.18
- CDIO 28.79
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.